Chennai Meenakshi Multispeciality Hospital Ltd
- Market cap
- ₹ 27 Cr.
- P/E
- 93.8x
- 52-week range
- 31.51 – 55.7
- ROCE
- −3.1%
- Dividend yield
- 0%
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- BSE
About
Chennai Meenakshi Multispeciality Hospital Limited is a provider of healthcare services. The Company is engaged in the business of design, construction, and/or running of all kinds of hospitals, dispensaries, clinics, laboratories and health clubs to provide comprehensive health care for society in various branches of medicine, such as General Surgery, General Medicine, Pediatrics, Neurology, Cardiology, ENT Ophthalmology, Radiology, Pathology, Gastroenterology, Urology, Thoracic Surgery, Plastic Surgery, Orthopedics and other allied specialties, and to provide facilities for post-graduate medical education. It is also focused on designing, manufacturing, importing, exporting, installing, maintaining and improving all kinds of medical and diagnostic equipment and instrumentation for hospitals, dispensaries, clinics, laboratories and health clubs at various centers throughout the country. The Company operates an approximately 100-bed hospital located in Mylapore.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →Chennai Meenakshi Multispeciality Hospital Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)93.8 against a typical 21: pricier than most peers (1st = cheapest).31st of 34
- Sales growth−0.7% against a typical +19.1% from a year earlier.29th of 31
- Share price, 3 months−10.2% against a typical −7.7%.20th of 33
- Size₹ 27.4 Cr. market value against a typical ₹ 83 Cr. (1st = largest).24th of 34
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10 | 10 | 10 | 9 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 9 |
| Expenses | 9 | 10 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 8 |
| Operating Profit | 1 | 0 | 0 | 0 | −0 | −0 | 0 | −1 | 0 | −0 | 0 | 0 |
| OPM % | 5.8% | 2.7% | 5% | 0.8% | −2.7% | −4.2% | 3.7% | −6% | 3.2% | −3.7% | 2.6% | 4.1% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | −0 | 0 | −0 | −1 | −1 | 0 | −1 | 0 | −1 | 0 | −0 |
| Tax % | 33.3% | −63.6% | 446.2% | −5% | −1.5% | −3.1% | 3.2% | −1.3% | −15.4% | −1.8% | — | −200% |
| Net Profit | 0 | −0 | −0 | −0 | −1 | −1 | 0 | −1 | 0 | −1 | −0 | 0 |
| EPS in Rs | 0.05 | −0.05 | −0.59 | −0.51 | −0.9 | −0.84 | 0.42 | −0.99 | 0.2 | −0.72 | −0.03 | 0 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 6%
- 5 Years
- 14%
- 3 Years
- −1%
- TTM
- 7%
- 10 Years
- —
- 5 Years
- 2%
- 3 Years
- —
- TTM
- 76%
- 10 Years
- 10%
- 5 Years
- 12%
- 3 Years
- 9%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Chennai Meenakshi Multispeciality Hospital Ltd | ₹ 34.00 | ₹ 27 Cr. | 93.8x | — | — | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.2x | 13.3x | — | 8.1% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 65.4x | 9x | — | 16.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 100.1x | 9x | — | 7.4% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 65x | 7x | — | 11.3% |
| Global Health | ₹ 1,165.00 | ₹ 31,449 Cr. | 68.5x | 9.6x | — | 11.8% |
Management
- Thanigai Vendan Moorrthy
- Chief Executive Officer
- M. S. Anantha Lakshmi
- Compliance Officer, Company Secretary
- Jayanthi Radhakrihshnan
- Managing Director, Executive Director
- Radhakrishnan Gomathy
- Managing Director, Woman Director
Prices are delayed and for information only. Nothing on this page is investment advice.